289 related articles for article (PubMed ID: 14563183)
1. Comparison between methotrexate and azathioprine in the treatment of chronic active Crohn's disease: a randomised, investigator-blind study.
Ardizzone S; Bollani S; Manzionna G; Imbesi V; Colombo E; Bianchi Porro G
Dig Liver Dis; 2003 Sep; 35(9):619-27. PubMed ID: 14563183
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate for induction of remission in refractory Crohn's disease.
McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
[TBL] [Abstract][Full Text] [Related]
3. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
Chande N; Townsend CM; Parker CE; MacDonald JK
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD000545. PubMed ID: 27783843
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators.
Feagan BG; Rochon J; Fedorak RN; Irvine EJ; Wild G; Sutherland L; Steinhart AH; Greenberg GR; Gillies R; Hopkins M
N Engl J Med; 1995 Feb; 332(5):292-7. PubMed ID: 7816064
[TBL] [Abstract][Full Text] [Related]
5. Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial.
Khanna R; Bressler B; Levesque BG; Zou G; Stitt LW; Greenberg GR; Panaccione R; Bitton A; Paré P; Vermeire S; D'Haens G; MacIntosh D; Sandborn WJ; Donner A; Vandervoort MK; Morris JC; Feagan BG;
Lancet; 2015 Nov; 386(10006):1825-34. PubMed ID: 26342731
[TBL] [Abstract][Full Text] [Related]
6. Combining infliximab with methotrexate for the induction and maintenance of remission in refractory Crohn's disease: a controlled pilot study.
Schröder O; Blumenstein I; Stein J
Eur J Gastroenterol Hepatol; 2006 Jan; 18(1):11-6. PubMed ID: 16357613
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate for induction of remission in refractory Crohn's disease.
Alfadhli AA; McDonald JW; Feagan BG
Cochrane Database Syst Rev; 2005 Jan; (1):CD003459. PubMed ID: 15674908
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate for the treatment of refractory Crohn's disease.
Lémann M; Chamiot-Prieur C; Mesnard B; Halphen M; Messing B; Rambaud JC; Gendre JP; Colombel JF; Modigliani R
Aliment Pharmacol Ther; 1996 Jun; 10(3):309-14. PubMed ID: 8791956
[TBL] [Abstract][Full Text] [Related]
9. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
Prefontaine E; Macdonald JK; Sutherland LR
Cochrane Database Syst Rev; 2009 Oct; (4):CD000545. PubMed ID: 19821270
[TBL] [Abstract][Full Text] [Related]
10. A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators.
Feagan BG; Fedorak RN; Irvine EJ; Wild G; Sutherland L; Steinhart AH; Greenberg GR; Koval J; Wong CJ; Hopkins M; Hanauer SB; McDonald JW
N Engl J Med; 2000 Jun; 342(22):1627-32. PubMed ID: 10833208
[TBL] [Abstract][Full Text] [Related]
11. Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study Group.
Sandborn WJ; Tremaine WJ; Wolf DC; Targan SR; Sninsky CA; Sutherland LR; Hanauer SB; McDonald JW; Feagan BG; Fedorak RN; Isaacs KL; Pike MG; Mays DC; Lipsky JJ; Gordon S; Kleoudis CS; Murdock RH
Gastroenterology; 1999 Sep; 117(3):527-35. PubMed ID: 10464128
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate for induction of remission in refractory Crohn's disease.
Alfadhli AA; McDonald JW; Feagan BG
Cochrane Database Syst Rev; 2003; (1):CD003459. PubMed ID: 12535475
[TBL] [Abstract][Full Text] [Related]
13. Early administration of azathioprine vs conventional management of Crohn's Disease: a randomized controlled trial.
Cosnes J; Bourrier A; Laharie D; Nahon S; Bouhnik Y; Carbonnel F; Allez M; Dupas JL; Reimund JM; Savoye G; Jouet P; Moreau J; Mary JY; Colombel JF;
Gastroenterology; 2013 Oct; 145(4):758-65.e2; quiz e14-5. PubMed ID: 23644079
[TBL] [Abstract][Full Text] [Related]
14. A controlled double blind study of azathioprine in the management of Crohn's disease.
Candy S; Wright J; Gerber M; Adams G; Gerig M; Goodman R
Gut; 1995 Nov; 37(5):674-8. PubMed ID: 8549944
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate for maintenance of remission in Crohn's disease.
Patel V; Macdonald JK; McDonald JW; Chande N
Cochrane Database Syst Rev; 2009 Oct; (4):CD006884. PubMed ID: 19821390
[TBL] [Abstract][Full Text] [Related]
16. Combination of cyclosporine, azathioprine and prednisolone for perianal fistulas in Crohn's disease.
Hinterleitner TA; Petritsch W; Aichbichler B; Fickert P; Ranner G; Krejs GJ
Z Gastroenterol; 1997 Aug; 35(8):603-8. PubMed ID: 9297775
[TBL] [Abstract][Full Text] [Related]
17. Cyclophosphamide pulse therapy followed by azathioprine or methotrexate induces long-term remission in patients with steroid-refractory Crohn's disease.
Schmidt C; Wittig BM; Moser C; Zeitz M; Stallmach A
Aliment Pharmacol Ther; 2006 Jul; 24(2):343-50. PubMed ID: 16842461
[TBL] [Abstract][Full Text] [Related]
18. Early azathioprine therapy is no more effective than placebo for newly diagnosed Crohn's disease.
Panés J; López-Sanromán A; Bermejo F; García-Sánchez V; Esteve M; Torres Y; Domènech E; Piqueras M; Gomez-García M; Gutiérrez A; Taxonera C; Sans M;
Gastroenterology; 2013 Oct; 145(4):766-74.e1. PubMed ID: 23770132
[TBL] [Abstract][Full Text] [Related]
19. [Compared azathioprine efficacy in ulcerative colitis and in Crohn's disease].
Kull E; Beau P
Gastroenterol Clin Biol; 2002 Apr; 26(4):367-71. PubMed ID: 12070412
[TBL] [Abstract][Full Text] [Related]
20. Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn's disease.
Neurath MF; Wanitschke R; Peters M; Krummenauer F; Meyer zum Büschenfelde KH; Schlaak JF
Gut; 1999 May; 44(5):625-8. PubMed ID: 10205197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
